Selective Interleukin-6 Trans-Signaling Blockade Is More Effective Than Panantagonism in Reperfused Myocardial Infarction

by Marc Jonathan George, MB ChB, PhD, Nur Hayati Jasmin, BSc, MRes, Valerie Taylor Cummings, Angela Richard-Loendt, BSc, MSc, Francesca Launchbury, BSc, Kevin Woollard, PhD, Tabitha Turner-Stokes, MB BChir, Ana Isabel Garcia Diaz, BSc, Mark Lythgoe, PhD, Daniel James Stuckey, BSc, DPhil, Aroon Dinesh Hingorani, MB BS, PhD, Derek William Gilroy, PhD
Published 2021-05-01